Skip to main content
News

VIPC’s Virginia Venture Partners Invests in Jeeva to Help Increase Patient Diversity in Clinical Trials – EIN Presswire

By September 2, 2022No Comments
Investing money into stock market investing comput 2022 08 01 04 22 50 utc

Investing money into stock market investing comput 2022 08 01 04 22 50 utcRICHMOND, VIRGINIA, UNITED STATES, August 31, 2022 /EINPresswire.com/ — Virginia Venture Partners, the equity investment program of Virginia Innovation Partnership Corporation (VIPC), today announced an investment in Manassas, Va.-based Jeeva. Jeeva provides a scalable eClinical Software as a Service (SaaS) platform that helps sponsors and contract research organizations (CROs) accelerate flexible clinical operations while minimizing burden on site staff and patients. Jeeva will use this investment towards commercialization of the SaaS platform to accelerate therapy development for therapeutic areas such as rare diseases, immunology, and oncology in the U.S. and in emerging markets such as Latin America and India, where the company has recently established strategic partnerships.

 

{iframe}https://www.einnews.com/pr_news/588554539/vipc-s-virginia-venture-partners-invests-in-jeeva-to-help-increase-patient-diversity-in-clinical-trials?utm_campaign=Investment%20Round%20Dec%202021&utm_medium=email&_hsmi=224589860&utm_content=224589860&utm_source=hs_email{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.